Marian Packham

Q: What Schools Are Affiliated With Marian Packham

Marian Packham is affiliated with the following schools: McMaster University, University of Toronto

Marian Packham's AcademicInfluence.com Rankings

Marian Packham

Biology

#5592

World Rank

#8107

Historical Rank

Biochemistry

#774

World Rank

#878

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Marian Packham Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Marian Aitchison Packham was Professor Emerita in biochemistry at University of Toronto. She researched biochemical and physiological activities of blood platelets. Education Packham studied Biochemistry at the University of Toronto, obtaining her BA in 1949 and completing her doctorate in 1954.

(See a Problem?)

Marian Packham's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Preparation of Suspensions of Washed Platelets from Humans (1972) (865)
Factors influencing platelet function: adhesion, release, and aggregation. (1970) (616)
Adenosine Diphosphate‐induced Platelet Aggregation in Suspensions of Washed Rabbit Platelets (1970) (405)
Factors responsible for ADP-induced release reaction of human platelets. (1975) (350)
The effect of plasma proteins on the interaction of platelets with glass surfaces. (1969) (304)
THE EFFECT OF ACETYLSALICYLIC ACID ON PLATELET FUNCTION (1968) (277)
Fibrinogen and ADP-induced platelet aggregation (1978) (247)
Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. (1977) (231)
Platelet function assays. (2003) (222)
Role of platelets in thrombosis and hemostasis. (1994) (215)
Effects on platelet function of removal of platelet sialic acid by neuraminidase. (1975) (210)
Platelets and diabetes mellitus. (1977) (191)
ALTERATION OF THE RESPONSE OF PLATELETS TO SURFACE STIMULI BY PYRAZOLE COMPOUNDS (1967) (181)
Localized protein accumulation in the wall of the aorta. (1967) (176)
Clinical pharmacology of platelets. (1977) (171)
Adherence of platelets to a collagen-coated surface: development of a quantitative method. (1973) (164)
Role of platelets in hepatic allograft preservation injury in the rat (1993) (150)
Influence of Apyrase on Stability of Suspensions of Washed Rabbit Platelets (1971) (148)
Properties of Washed Human Platelets (1977) (144)
Effect of the Concentration of Ca2+ in the Suspending Medium on the Responses of Human and Rabbit Platelets to Aggregating Agents (1989) (143)
In Vitro and in Vivo Functions of Thrombin-Treated Platelets (1976) (141)
Isolation of human platelets from plasma by centrifugation and washing. (1989) (140)
Deposition of formed elements of blood on the intima and signs of intimal injury in the aorta of rabbit, pig, and man. (1972) (132)
Response of platelets to tissue injury. (1968) (129)
Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. (1976) (127)
Survival of rabbit platelets treated in vitro with chymotrypsin, plasmin, trypsin, or neuraminidase. (1979) (116)
Rapid clearance of procoagulant platelet‐derived microparticles from the circulation of rabbits (2006) (112)
Thromboembolism: A Manifestation of the Response of Blood to Injury (1970) (107)
Effect of Repeated Treatment of Rabbit Platelets with Low Concentrations of Thrombin on their Function, Metabolism and Survival (1973) (105)
Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. (1990) (97)
Platelet aggregation and release: effects of low concentrations of thrombin or collagen. (1973) (96)
Comparison of Fibrinogen Association With Normal and Thrombasthenic Platelets on Exposure to ADP or Chymotrypsin (1979) (93)
The role of platelets in the development and complications of atherosclerosis. (1986) (92)
Release of 14C-serotonin during initial platelet changes induced by thrombin, collagen, or A23187. (1977) (91)
Synergism between platelet aggregating agents: the role of the arachidonate pathway. (1977) (90)
The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. (1979) (90)
Reduced Membrane Fluidity in Platelets From Diabetic Patients (1990) (85)
The Effect of Prostaglandin E1 on Platelet Function in Vitro and in Vivo (1970) (84)
The Platelet Cytoskeleton Stabilizes the Interaction between and Its Ligand and Induces Selective Movements of Ligand-occupied Integrin (*) (1996) (83)
Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium (1987) (83)
Fibrinogen and ADP-induced platelet aggregation. (1978) (80)
Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. (1993) (79)
Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen. (1980) (77)
Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady‐state senescence (2004) (73)
Effect of adenine compounds on platelet aggregation. (1969) (73)
Density subpopulations of rabbit platelets: size, protein, and sialic acid content, and specific radioactivity changes following labeling with 35S-sulfate in vivo. (1981) (73)
Vessel injury, platelet adherence, and platelet survival. (1983) (71)
Factors Influencing the Deaggregation of Human and Rabbit Platelets (1983) (71)
The Role of Blood and Platelets in Atherosclerosis and the Complications of Atherosclerosis (1975) (69)
Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium. (1987) (69)
Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin. (1979) (69)
Platelet adherence to fibrin and collagen. (1968) (69)
Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN. (1998) (67)
Interactions of polylysine with platelets. (1971) (66)
Effects of the cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits, and rats. (1987) (65)
Effects of Penicillin G on Platelet Aggregation, Release, and Adherence to Collagen 1 (1973) (65)
Platelets, blood flow, and the vessel wall. (1990) (63)
Platelet Function Inhibitors (1983) (62)
Platelets, thrombosis and atherosclerosis. (1977) (61)
Effects of Ethanol on Pathways of Platelet Aggregation In Vitro (1988) (61)
The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae. (1980) (60)
Quantitative radioisotopic measurement and scanning electron microscopic study of platelet adherence to a collagen-coated surface and to subendothelium with a rotating probe device. (1979) (60)
Effects of Plasmin on Rabbit Platelets (1985) (56)
Platelet Function and Myocardial Infarction (1969) (54)
Methods for Detection of Hypersensitive Platelets (1978) (53)
Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients. (1987) (53)
Reversibility of the association of fibrinogen with rabbit platelets exposed to ADP. (1980) (52)
Inhibition of platelet adherence to damaged surface of rabbit aorta. (1975) (51)
Conditions Affecting the Responses of Human Platelets to Epinephrine (1988) (50)
Normal and abnormal haemostasis. (1977) (49)
The Behavior of Platelets at Foreign Surfaces (1988) (49)
Effect of viruses on platelet aggregation and platelet survival in rabbits. (1978) (48)
Platelet-surface interactions: relationship to thrombosis and hemostasis. (1967) (47)
Inositol phospholipid metabolism in human platelets stimulated by ADP. (1990) (46)
Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective. (2005) (46)
Aspirin in the treatment of cardiovascular disease: a review. (1983) (43)
Effect of ionophore A23, 187 on thrombin-degranulated washed rabbit platelets. (1975) (42)
Prostaglandins I2 and E1 reduce rabbit and human platelet adherence without inhibiting serotonin release from adherent platelets. (1979) (42)
Inhibition of platelet adherence to a collagen-coated surface by nonsteroidal anti-inflammatory drugs, pyrimido-pyrimidine and tricyclic compounds, and lidocaine. (1974) (42)
Survival of density subpopulations of rabbit platelets: use of 51Cr-or 111In-labeled platelets to measure survival of least dense and most dense platelets concurrently. (1983) (41)
Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid. (1993) (39)
Degranulation of Human Platelets by the Thrombin Receptor Peptide SFLLRN: Comparison with Degranulation by Thrombin (1993) (39)
Separation of thrombin-treated platelets from normal platelets by density-gradient centrifugation. (1979) (38)
Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen. (1981) (38)
Modification of platelet adherence to protein-coated surfaces. (1973) (37)
Immunocytochemical localization of fibrinogen during thrombin-induced aggregation of washed human platelets. (1988) (37)
Reactions of 14C-ADP and 14C-ATP with washed platelets from rabbits. (1971) (36)
Adenosine diphosphate(ADP) does not induce thromboxane A2 generation in human platelets. (2002) (36)
Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: Direct measurement of percent release of β‐thromboglobulin and assessment by flow cytometry of P‐selectin expression (1996) (36)
Characterization of the sulfated glycosaminoglycan on the surface and in the storage granules of rabbit platelets. (1979) (34)
Prostaglandins and platelets. (1980) (34)
Thrombin-induced inositol trisphosphate production by rabbit platelets is inhibited by ethanol. (1988) (33)
Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity (2007) (32)
Similarities and differences between rabbit and human platelet characteristics and functions. (1992) (32)
Platelets and thrombosis in the development of atherosclerosis and its complications. (1978) (31)
Effects of Cephalothin and Penicillin G on Platelet Function in Vitro (1977) (31)
Pharmacology of platelet-affecting drugs. (1980) (31)
Labeling of the releasable adenine nucleotides of washed human platelets. (1977) (30)
Platelets and diabetes mellitus. (1977) (29)
Effect of Newcastle disease virus on human or rabbit platelets. Aggregation and loss of constituents. (1973) (29)
Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphate-induced responses and enhanced fibrinogen binding in a medium with low calcium levels. (1988) (29)
In Vitro Effects of Ethanol on Rabbit Platelet Aggregation, Secretion of Granule Contents, and Cyclic AMP Levels in the Presence of Prostacyclin (1989) (28)
The Effect of Pyrazole Compounds on Thrombin-Induced Platelet Aggregation∗ (1969) (27)
The effect of acetylsalicylic acid and indomethacin on rabbit platelet adherence to collagen and the subendothelium in the presence of a low or high hematocrit. (1978) (27)
Mechanisms in thrombosis. (1984) (26)
Acute administration of ethanol to rabbits inhibits thrombus formation induced by indwelling aortic catheters. (1990) (26)
Platelet aggregation and the platelet release reaction in thromboembolism. (1970) (26)
The use of the synthetic peptide, Gly-Pro-Arg-Pro, in the preparation of thrombin-degranulated rabbit platelets. (1982) (26)
Platelet adherence to the vessel wall and to collagen-coated surfaces. (1978) (26)
Effects of Tris on Responses of Human and Rabbit Platelets to Aggregating Agents (1984) (26)
Effects of variant gamma chains and sialic acid content of fibrinogen upon its interactions with ADP-stimulated human and rabbit platelets (1984) (26)
The effect of glucose on adenosine diphosphate-induced platelet aggregation. (1970) (26)
Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets. (1987) (25)
Reactions of Polylysine with Human Platelets in Plasma and in Suspensions of Washed Platelets (1976) (25)
MODIFICATION OF PLATELET FUNCTION (1972) (25)
Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses. (1991) (24)
Platelet sialic acid and platelet survival after aggregation by ADP (1980) (23)
Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival. (1985) (23)
Studies of the biological synthesis of glucuronides. (1952) (23)
Effect of Aspirin and Sodium Salicylate on Thrombosis, Fibrinolysis, Prothrombin Time, and Platelet Survival in Rabbits With Indwelling Aortic Catheters (1983) (22)
Investigation of possible mechanisms of pyridoxal 5'-phosphate inhibition of platelet reactions. (1980) (22)
AMP inhibition of reactions of ADP with washed platelets from humans and rabbits. (1972) (22)
The effect of aggregating agents on oxidative metabolism of rabbit platelets. (1971) (21)
Comparison of methods of measuring loss of cytoplasmic constituents from platelets. (1976) (21)
THE ROLE OF THROMBOGENIC FACTORS IN ATHEROSCLEROSIS (1968) (20)
Characteristics of Thrombin-Degranulated Human Platelets: Development of a Method that Does not Use Proteolytic Enzymes for Deaggregation (1991) (20)
Conditions influencing platelet lysis. (1975) (20)
Inhibition of platelet adherence to a collagen-coated surface by agents that inhibit platelet shape change and clot retraction. (1974) (20)
Effect of cAMP Phosphodiesterase Inhibitors on ADP-Induced Shape Change, cAMP and Nucleoside Diphosphokinase Activity of Rabbit Platelets (1982) (20)
Ticlopidine Facilitates the Deaggregation of Human Platelets Aggregated by Thrombin (1994) (20)
Historical perspective on ADP-induced platelet activation (2011) (19)
Effect of Amino Sugars on Platelet Aggregation and on Fibrinogen Binding (1984) (19)
Dynamics of thrombus formation. (1977) (19)
The effect of glucose on the platelet response to release-inducing stimuli. (1972) (19)
Effects of ethanol on platelet responses associated with adhesion to collagen. (1999) (19)
Platelet Accumulation on Fibrin-coated Polyethylene: Role of Platelet Activation and Factor XIII (1995) (18)
Reinvestigation of the fate of injected glucuronic acid, glucurone and naphthol glucuronide in the rat. (1955) (18)
Deaggregation of Human Platelets Aggregated by Thrombin (1985) (18)
Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated with thrombin. (1985) (17)
Measurement of Fibrinogen Concentrations in Suspensions of Washed Rabbit and Human Platelets by Radioimmunoassays (1985) (17)
Lack of Stability of Aggregates after Thrombin-Induced Reaggregation of Thrombin-Degranulated Platelets (1992) (17)
Effects of ethanol on rabbit platelet responses to collagen in vitro and ex vivo and on platelet adhesion to de-endothelialized aortae in vivo. (1987) (17)
Interactions of nucleoside di- and triphosphates with rabbit platelets. (1974) (17)
Effects of sodium periodate on platelet functions. (1976) (17)
Thrombosis and Atherosclerosis (1974) (16)
Experimental modification of platelet survival. (1977) (16)
The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction. (1982) (16)
Factor VII survival and turnover in dogs. (1967) (16)
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. (1989) (16)
Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. (1999) (16)
Transfer of adenine nucleotides between the releasable and nonreleasable compartments of rabbit blood platelets (1975) (16)
Pretreatment of Human Platelets with Plasmin Inhibits Responses toThrombin, but Potentiates Responses to Low Concentrations of Aggregating Agents, Including the Thrombin Receptor Activating Peptide, SFLLRN (1997) (16)
Contrasting Effects of Thrombin and the Thrombin Receptor Peptide, SFLLRN, on Aggregation and Release of 14C-Serotonin by Human Platelets Pretreated with Chymotrypsin or Serratia marcescens Protease (1995) (16)
Platelet interactions with the endothelium and the subendothelium: the role of thrombin and prostacyclin. (1979) (16)
Loss of sulfated proteoglycan from the surface of rabbit platelets during adenosine 5'-diphosphate-induced aggregation. (1976) (16)
Factors Influencing the Deaggregation of Chymotrypsin-Treated Human Platelets Aggregated by Fibrinogen (1983) (16)
Adenine nucleotides in thrombin-degranulated platelets: effect of prolonged circulation in vivo. (1977) (16)
Platelets, endothelium, and vessel injury. (1985) (15)
The influence of prostaglandin E1 on platelet adherence and injury in preserved rat liver allografts. (1996) (15)
Effects of variant gamma chains and sialic acid content of fibrinogen upon its interactions with ADP-stimulated human and rabbit platelets. (1984) (15)
Drugs inhibiting platelet function (1973) (15)
Platelet activation--an overview. (1987) (15)
Arachidonate-Induced Fibrinogen Binding To Thrombin-Degranulated Rabbit Platelets Is Independent Of Released ADP (1982) (15)
Concurrent measurement of the survival of two populations of rabbit platelets labeled with either two PKH lipophilic dyes or two concentrations of biotin. (2002) (14)
Drug effects on platelet adherence to collagen and damaged vessel walls. (1978) (14)
Eicosapentaenoic Acid Interferes with U46619-Stimulated Formation of Inositol Phosphates in Washed Rabbit Platelets (1989) (14)
Comparison of the Interactions of Fibrinogen and Soluble Fibrin with Washed Rabbit Platelets Stimulated with ADP (1985) (14)
Enzyme activities on the platelet surface in relation to the action of adenosine diphosphate. (1975) (13)
Aggregation-related association of lipid with the cytoskeleton of rabbit and human platelets prelabeled with [3H]palmitic acid. Similar effects of adenosine diphosphate- and thrombin-induced aggregation. (1988) (13)
Platelet adhesion. (1984) (13)
Unexpected Effects of Aurin Tricarboxylic Acid on Human Platelets (1992) (12)
Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects (2010) (12)
Platelet reactions. (1971) (11)
Focal aortic injury caused by cannulation: increased plasma protein accumulation and thrombosis. (2009) (11)
Ethanol Inhibits Thrombin-induced Secretion of the Contents of Human Platelet Dense and α-Granules and Lysosomes (1998) (11)
Enhanced collagen-induced responses of platelets from rabbits with diet-induced hypercholesterolemia are due to increased sensitivity to TxA2. Response inhibition by chronic ethanol administration in hypercholesterolemia is due to reduced TxA2 formation. (1994) (11)
Thrombogenic and Nonthromboge0nic Biological Surfaces (1987) (11)
Platelet aggregation: relevance to thrombotic tendencies. (1978) (11)
Isolation and kinetic studies of nucleoside diphosphokinase from human platelets and effects of cAMP phosphodiesterase inhibitors. (1986) (10)
Persistence of phosphatidylserine exposure on activated platelets in vivoin rabbits (2007) (10)
The fate of injected sodium glucuronate and glucurone in the rat. (1954) (10)
The Effect of Thrombin on Platelet Accumulation on the Vessel Wall - Influence of Heparin and Aspirin (1983) (10)
Expression of Fibrinogen on the Surface of ADP-Stimulated Platelets: Comparison of Human and Rabbit Platelets (1988) (10)
Changes in the properties of platelets from rats with experimentally induced shortened platelet survival. (1983) (10)
Investigation of In Vivo Factors that May Influence Platelet Survival and Density (1979) (10)
Young steady-state rabbit platelets do not have an enhanced capacity to expose procoagulant phosphatidylserine (2018) (10)
The Fibrinogen γ Chain Dodecapeptide Inhibits Agonist-induced Aggregation of Rabbit Platelets and Fibrinogen Binding to Rabbit Glycoprotein IIb-IIIa (1999) (10)
Effects on the buoyant density of rabbit platelets of ADP and agents that increase the concentration of cyclic AMP. (1985) (9)
Responses to aggregating agents after cleavage of GPIb of human platelets by the O-sialoglycoprotein endoprotease from Pasteurella haemolytica- potential surrogates for Bernard-Soulier platelets? (2000) (9)
Platelets, thrombosis and atherosclerosis. (1978) (9)
Effect of calcium concentration and inhibitors on the responses of platelets stimulated with collagen: contrast between human and rabbit platelets. (1991) (9)
Probenecid Inhibits Platelet Responses to Aggregating Agents in Vitro and Has a Synergistic Inhibitory Effect with Penicillin G (1996) (9)
Effects of thrombin and the thrombin receptor activating peptide, SFLLRN, on redistribution of platelet alpha-granule contents are similar and independent of the extent of thromboxane formation. (1995) (9)
Platelets, Thrombosis and Drugs (2012) (9)
Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2. (1991) (8)
Most Apyrase Preparations Are Impure and Contain Inhibitors of Cathepsin G: Suggestions for Use of Apyrase in Preparation and Stabilization of Platelet Suspensions (1999) (8)
Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function. (2002) (8)
Effect of aspirin and sodium salicylate on thrombosis, fibrinolysis, prothrombin time, and platelet survival In rabbits with indwelling aortic catheters. (1983) (8)
Standardization of Collagen: Consideration of Current Practices in Testing Collagen-Induced Aggregation (1984) (8)
The role of platelets in the early and late stages of atherosclerosis and its clinical complications. (1988) (7)
Effects of Penicillin G and Cephalothin on Platelet Function in Vivo (1976) (7)
Platelets in Thrombotic and Non-thrombotic Disorders: History of platelets (2002) (7)
Effects of Alcohol Withdrawal on Responses of Platelets from Alcoholics - A Study Using Platelet-Rich Plasma from Blood Anticoagulated with D-Phenylalanyl-L-prolyl-L-arginyl Chloromethyl Ketone (FPRCH2CI) (1990) (7)
Effect of reserpine on adenosive uptake and metabolism, and subcellular transport of platelet adenosine triphosphate in washed rabbit platelets. (1977) (6)
Acute in vitro effects of ethanol on responses of platelets from cholesterol-fed and Watanabe heritable hyperlipidemic rabbits. (1992) (6)
Agglutination of Rabbit Platelets in Plasma by the Thrombin Inhibitor D-phenylalanyl-L-prolyl-L-arginyl Chloromethyl Ketone (1990) (6)
Effects of chronic administration of ethanol on platelets from rabbits with diet-induced hypercholesterolemia. Unchanged characteristics and responses to ADP but reduction of enhanced thrombin-induced, TxA2-independent platelet responses. (1994) (6)
Non-Steroidal Anti-Inflammatory Drugs, Pyrimido-Pyrimidine Compounds and Tricyclic Compounds (1975) (6)
Lack of Effect of UPD, UDPG, and Glucosamine on Platelet Reactions with Collagen (1974) (6)
The unrealized potenital of animal diseases in the study of human diseases. (1968) (5)
Platelet sialic acid and platelet survival after aggregation by ADP. (1980) (5)
Changes in Phosphoinositides in Rabbit Platelets during Clot Formation. Comparison of Platelets Stimulated by ADP or by Thrombin in the Presence of Polymerising Fibrin. (1990) (5)
Inhibition by Ethanol of Thrombus Formation Induced by Indwelling Aortic Catheters in Rabbits (1991) (5)
Polyphosphoinositide Changes in Rabbit Platelets Stimulated with Platelet Activating Factor During the Formation of Platelet-fibrin Clots. (1992) (5)
Differences between platelet phosphoinositide metabolism stimulated by thrombin or SFLLRN are not accounted for by interaction of thrombin with glycoprotein Ib (1997) (5)
Thrombosis and Endothelial Injury in Atherogenesis (1977) (5)
Effects of reserpine on rabbit platelet aggregation and adherence to collagen or injured rabbit aorta. (1977) (5)
Vessel Injury, Thrombosis, and the Progression and Regression of Atherosclerotic Lesions (1983) (4)
Plasma Fibronectin Is Not Involved in ADP-Induced Aggregation of Rabbit Platelets (1980) (4)
Platelets and diabetes mellitus. (1984) (4)
The assessment of platelet adherence. (1967) (4)
Separation of Degranulated Platelets from Normal Platelets (1977) (4)
In vitro Methods and the Study of Platelet Mechanisms (1981) (4)
Association of fibrinogen with human platelets pretreated with chymotrypsin or aggregated with ADP or thrombin: an immunocytochemical study. (1989) (4)
Platelets in Thrombotic and Non-thrombotic Disorders: Aggregation (2002) (4)
Localization of fibrinogen during ADP- or thrombin-induced aggregation of washed rabbit platelets. (1990) (4)
An investigation into the role of coagulation factor XIII in ADP-induced aggregation and fibrinogen binding with rabbit platelets. (1982) (4)
Identical behavior of fibrinogen and asialo-fibrinogen in reactions with platelets during ADP-induced aggregation. (1980) (4)
Role of Platelets in Stroke and Transient Ischemic Attack (1981) (3)
Palmitic acid-labeled lipids selectively incorporated into platelet cytoskeleton during aggregation (1990) (3)
VITAMIN B6 AS AN ANTITHROMBOTIC AGENT (1981) (3)
Is Platelet Heterogeneity Due to Ageing or Thrombopoiesis (1990) (3)
Mode of action of acetyl salicylic acid (1982) (3)
Thrombin-induced inositol phosphate production by platelets from rats with diet-induced or genetically determined hypercholesterolemia. (1990) (3)
4 – Pharmacology of Antiplatelet Agents and Their Role in Coronary Disease (1983) (3)
PLATELET AGGREGATION INDUCED BY SWINE INFLUENZA VACCINE (1978) (2)
Polymerizing Fibrin Decreases the Polyphosphoinositides in Chymotrypsin‐Treated Human Platelets (1994) (2)
Atherogenesis and its relation to stroke. (1982) (2)
Inhibition of platelet adherence to damaged vessel wall by drugs. (1977) (2)
The role of platelets in thrombosis and atherosclerosis. (1967) (2)
Vessel injury, thrombosis and atherosclerosis (1984) (2)
Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid (2005) (1)
IMMUNOCYTOCHEMICAL LOCALIZATION OF FIBRINOGEN DURING THROMBIN-INDUCED AGGREGATION OF HUMAN PLATELETS (1987) (1)
Exogenous diacylglycerols synergize with PAF with human platelets, but inhibit PAF-induced responses of rabbit platelets. (1996) (1)
Effect of drugs of platelets and complications of vascular disease. (1977) (1)
Effects of reserpine and serotonin on adenine nucleotide matabolism and glucose oxidation of washed rabbit platelets. (1977) (1)
Incorporation of lipids labeled with various fatty acids into the cytoskeleton of aggregating platelets (1991) (1)
Report of the working party on platelets. Stages in the interaction of platelets with collagen. (1976) (1)
Modifications of Platelets that Affect Platelet Adherence to Collagen or Damaged Aorta aud Platelet Survival (1975) (1)
Platelet Survival In Relation To Vessel Wall Injury (1981) (1)
Pathways of Thrombin-Induced Aggregation and Release with Human and Rabbit Platelets (1977) (1)
Inhibition of Collagen- or Thrombin-Induced Shape Change of Rabbit Platelets (1975) (1)
Platelet Reactions in Thrombosis (1991) (1)
Thrombogenic and nonthrombogenic biological surfaces. (1987) (1)
platelets Willebrand factor to support the ADP-induced aggregation of human Effect of calcium ion concentration on the ability of fibrinogen and von (2011) (1)
Non-steroidal anti-inflammatory agents and coronary heart disease. (2009) (1)
B 2. Stages in the Interaction of Platelets with Collagen (1976) (0)
Concentrations Of cAMP Phosphodiesterase Inhibitors That Block The ADP-Induced Shape Change Of Rabbit Platelets Do Not Increase Platelet cAMP (1981) (0)
Investigation Of The Origin Of The Density Heterogeneity Of Rabbit Platelets (1981) (0)
J. Fraser Mustard, M.D., Ph.D. (November 16, 2011) (2012) (0)
100 years of biochemistry at the University of Toronto, 1908-2008 : (2014) (0)
ETHANOL INHIBITS RABBIT PLATELET RESPONSES TO COLLAGEN IN VITRO BUT DOES NOT AFFECT RABBIT PLATELET ADHERENCE TO DE-ENDOTHELIALIZED A0RTAE IN VIVO (1987) (0)
The Role of Ca2+I in Procoagulant Surface Expression and Apoptosis in Human Platelets. (2005) (0)
To the editor : Adenosine diphosphate ( ADP ) does not induce thromboxane A 2 generation in human platelets (0)
in human platelets generation 2 Adenosine diphosphate (ADP) does not induce thromboxane A (2011) (0)
2.P.128 Recombinant apolipoprotein(a) and lipoprotein(a) enhance platelet responses to a thrombin receptor-activating peptide (1997) (0)
Quantitation of Platelet Adherence to Rabbit Aortae and Platelet Survival After two Injuries with a Balloon Catheter (1979) (0)
The absorption of labelled glucose, sodium glucuronate, and glucurone from the gastrointestinal tract of the rat. (1956) (0)
Platelets: Pathophysiology and Antiplatelet Drug Therapy By Harvey J. Weiss (review) (2015) (0)
Effects of Inhibitors of ADP-induced Aggregation on Platelet Nucleo-sidediphosphate Kinase (NDK) Activity (1975) (0)
Role of secreted adenosine diphosphate in the synergistic effects of cathepsin G on human platelets. (1999) (0)
Fibrinogen and A D Pinduced Platelet Aggregation (2017) (0)
The Mechanisms of Action of Drugs that Modify Platelet and Vessel Wall Function (1980) (0)
THE EFFECT OF ENZYMATIC TREATMENT OF RABBIT PLATELETS ON THE BINDING OF IMMUNOGLOBULIN G TO THE SURFACE (1987) (0)
Commentary. Drugs inhibiting platelet function. (1973) (0)

This paper list is powered by the following services:

Other Resources About Marian Packham

en.wikipedia.org

What Schools Are Affiliated With Marian Packham?

Marian Packham is affiliated with the following schools: